KIAA1211 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.069000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.950400E-01
Normal-vs-Stage2
1.604170E-01
Normal-vs-Stage3
4.639200E-01
Normal-vs-Stage4
4.710400E-02
Stage1-vs-Stage2
6.184000E-01
Stage1-vs-Stage3
9.947000E-01
Stage1-vs-Stage4
1.449750E-01
Stage2-vs-Stage3
6.905000E-01
Stage2-vs-Stage4
6.645900E-02
Stage3-vs-Stage4
2.238600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.214400E-01
Normal-vs-AfricanAmerican
2.612000E-01
Normal-vs-Asian
1.822600E-01
Caucasian-vs-AfricanAmerican
3.992800E-01
Caucasian-vs-Asian
7.545600E-01
AfricanAmerican-vs-Asian
4.758200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.896590E-01
Normal-vs-Female
2.355400E-01
Male-vs-Female
5.851800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.376000E-01
Normal-vs-Age(41-60Yrs)
1.734400E-01
Normal-vs-Age(61-80Yrs)
2.383800E-01
Normal-vs-Age(81-100Yrs)
2.754800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.776400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.623600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.683800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.107200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.053600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.070200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.491610E-01
Normal-vs-Daily Drinker
4.253600E-01
Normal-vs-Weekly Drinker
3.159800E-01
Normal-vs-Occasional Drinker
3.288600E-01
Normal-vs-Social Drinker
7.966200E-02
Non Drinker-vs-Daily Drinker
9.508400E-02
Non Drinker-vs-Weekly Drinker
9.171200E-01
Non Drinker-vs-Occasional Drinker
4.681800E-01
Non Drinker-vs-Social Drinker
6.659600E-01
Daily Drinker-vs-Weekly Drinker
2.656800E-01
Daily Drinker-vs-Occasional Drinker
1.280230E-01
Daily Drinker-vs-Social Drinker
2.201400E-01
Weekly Drinker-vs-Occasional Drinker
5.115800E-01
Weekly Drinker-vs-Social Drinker
8.310000E-01
Occasional Drinker-vs-Social Drinker
3.389800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.783000E-01
Normal-vs-Grade 2
7.832300E-02
Normal-vs-Grade 3
1.082430E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.314200E-01
Grade 1-vs-Grade 3
9.853400E-01
Grade 1-vs-Grade 4
3.783000E-01
Grade 2-vs-Grade 3
8.900800E-01
Grade 2-vs-Grade 4
7.832300E-02
Grade 3-vs-Grade 4
1.082430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.797400E-01
Normal-vs-NonDiabetic
2.191200E-01
Diabetic-vs-NonDiabetic
4.897400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.943000E-01
Normal-vs-NoPancreatitis
2.264200E-01
Pancreatitis-vs-NoPancreatitis
3.522800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.795400E-01
Normal-vs-N1
1.604390E-01
N0-vs-N1
8.301000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.775250E-01
Normal-vs-TP53-NonMutant
2.197400E-01
TP53-Mutant-vs-TP53-NonMutant
7.133000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
